JayeshMehtaMD
Hematology • Chicago, ILHematologic Oncology
Chez Family Professor of Myeloma Research, Northwestern University Feinberg School of Medicine, and Director, Stem Cell Transplantation and Cell Therapy Program, Northwestern Memorial Hospital and Robert H Lurie Comprehensive Cancer Center
Dr. Mehta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
675 N Saint Clair St
Galter 21-100
Chicago, IL 60611Phone+1 312-695-0990Fax+1 312-695-3098- Is this information wrong?
Education & Training
Royal Marsden HospitalSr Registrar, Bone marrow transplantation and hematologic malignancies, 1992 - 1996- Hadassah University HospitalResident, Bone marrow transplantation, 1991 - 1992
- King Edward VII Memorial Hospital (KEM Hospital)MD, House Office & Registrar, 1987 - 1990
- Seth GS Medical CollegeMBBS, 1981 - 1986
Seth G.S. Medical CollegeClass of 1986
Certifications & Licensure
IL State Medical License 2001 - 2026
SC State Medical License 1999 - 2001
AR State Medical License 1996 - 1999- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Zhao LR, Kessler J, Singhal S, Mehta J. Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders. US Patent 8524655, 2013
- Zhao LR, Kessler J, Singhal S, Mehta J. Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders. European Patent EP 1817047 B1, 2012
- Zhao LR, Mehta J, Singhal S, Kessler J. Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders. Australian Patent 2005306894, 2012
- Join now to see all
Clinical Trials
- Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia Start of enrollment: 2010 Apr 12
- A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD Start of enrollment: 2010 Oct 07
Publications & Presentations
PubMed
- 9 citationsPembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investiga...Locke J Bryan, Carla Casulo, Pamela B Allen, Scott E Smith, Hatice Savas, Gary L Dillehay, Reem Karmali, Barbara Pro, Kaitlyn L Kane, Latifa A Bazzi, Joan S Chmiel, Br...> ;JAMA Oncology. 2023 May 1
- 1 citationsClinicopathologic and genetic evaluation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21) in adult patients.Taylor Zak, Juehua Gao, Amir Behdad, Jayesh Mehta, Jessica K Altman, Peng Ji, Xinyan Lu, Madina Sukhanova> ;Leukemia & Lymphoma. 2022 Dec 1
- 1 citationsThe non-steroidal anti-inflammatory drug salsalate provides safe and effective control of mucositis-unrelated pain during autologous and allogeneic hematopoietic stem ...Steven Trifilio, Leo I. Gordon, Halina Rubin, N. Grosshans, Jayesh Mehta> ;Supportive Care in Cancer. 2021 Jul 1
- Join now to see all
Journal Articles
- Treatment-related mortality rates on Total Therapy protocolsMehta J, Blood, 9/9/2010
- Individual drug dose-intensity and outcome in myelomaMehta J, Blood, 8/31/2010
- Successful treatment of IgM-mediated autoimmune hemolytic anemia with bortezomibCarson KR, Beckwoth LG, Mehta J, Blood, 1/1/2010
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classi...Jayesh Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Comprehensive Investigation of White Blood Cell and Gene Expression Profiles As Risk Factors for Multiple Myeloma in African AmericansJayesh Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Allogeneic hematopoietic stem cell transplantation for myeloma: does the melphalan dose matter? Abstract #3035Mehta J, Chunduri S, Dobogai L, Singhal S, Rondelli D, Blood, 1/1/2007
- Join now to see all
Other
- Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders.Zhao LR, Kessler J, Singhal S, Mehta J, US Patent 8,524,655
9/3/2013 - Treatment-related mortality rates on Total Therapy protocols.Mehta J, Blood e-Letter
http://www.bloodjournal.hematologylibrary.org/cgi/eletters/115/21/4168
9/9/2010 - Individual drug dose-intensity and outcome in myeloma.Mehta J, Blood e-Letter
http://www.bloodjournal.hematologylibrary.org/cgi/eletters/blood-2010-01-264333
8/31/2010 - Join now to see all
Other Languages
- Gujarati, Hindi, Marathi
Hospital Affiliations
Northwestern Memorial HospitalChicago, Illinois
External Links
- Northwestern Scholarshttps://www.scholars.northwestern.edu/en/persons/jayesh-mehta
- Northwestern Universityhttp://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=12650
- Lurie Cancer Centerhttp://cancer.northwestern.edu/public/why_northwestern/search_physician/Physician_info.cfm?id=151
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
